Teva Pharmaceuticals USA Inc., Walgreens, and others have won the dismissal of a proposed class suit by a New Jersey federal court for the time being for manufacturing and selling contaminated generic diabetes drugs.
Seven named individuals and one company sued 16 manufacturers and four pharmacy chains for manufacturing and marketing metformin drugs that had become worthless due to contamination with N-nitrosodimethylamine (NDMA), a likely human carcinogen.
But consumers lack prestige for not claiming they bought the drugs tainted, and they couldn’t link each defendant’s behavior to at least one injured plaintiff, the U.S. District Court for the district …
/complicationsofdiabetes-GettyImages-1302948460-829d6ca13e4945eab127f8dd9d87b773.jpeg "Sort 2 Diabetes Issues: Overview and Extra"){kind=small}
